ArticleClinical case reports2026
A Case Illustrating Challenges: Early-Onset Signet Ring Cell Rectal Carcinoma With Fulminant Peritoneal Progression.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Signet ring cell carcinoma (SRCC) of the rectum is a rare histologic subtype and is often associated with aggressive behavior and poor outcomes, particularly in young patients. We report a 19-year-old male who presented with acute intestinal obstruction and was diagnosed with rectal SRCC, radiologically staged as cT2N1bM0, acknowledging the limitations of radiologic staging in this histologic subtype. An emergency diversion colostomy was performed, followed by long-course neoadjuvant chemoradiotherapy (nCRT). Three months later, the patient presented again with abdominal pain and cachexia. Radiology showed evidence of extensive peritoneal disease. Exploratory surgery revealed diffuse peritoneal carcinomatosis, preventing the planned complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Further treatment options were discarded by the family. The disease progressed rapidly, and the patient passed away one month later. This case highlights the challenges in early-onset rectal SRCC. The aggressive clinical course even after long-course neoadjuvant chemoradiotherapy, the limitations of current treatment protocols, and the high risk of understaging through conventional radiology are highlighted in this case report.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.